Released: Last reviewed:
Editorial reviews of 10 leading U.S. telehealth providers for compounded and brand-name GLP-1 weight-management programs. NexLife is ranked #1 at 94/100 on methodology v4.1 (seven weighted categories); the other providers’ scores are from the May 2026 review (v3.0 rubric), and re-scoring on v4.1 is pending.
Compounded semaglutide + tirzepatide. Licensed physicians (NexLife Medical Group). Three state-licensed 503A pharmacies named on its plan pages. Provider oversight included. All 50 states. Care360 support with a 1:1 wellness-coach call. Klarna & Affirm accepted.
Trade-offs to know: Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus® / Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
Or call (949) 818-8000
All 10 reviewed providers. NexLife is scored on methodology v4.1; the other scores are from the May 2026 review (v3.0 rubric), and re-scoring on v4.1 is pending.
UPDATED
Ranked #1 at 94/100 on methodology v4.1. Flat, dose-independent compounded semaglutide + tirzepatide with no membership, licensed physicians (NexLife Medical Group), three state-licensed 503A pharmacies named on its plan pages, Care360 support with a personalized nutrition plan and a 1:1 wellness-coach call, all 50 states. Lab work is not stated as included. You can check its status yourself on LegitScript.
UPDATED
Brand-name Wegovy® and Ozempic® through standard insurance/cash channels. Strong on access and brand-name supply. Pricing is dose-independent on Wegovy but caps high without insurance.
UPDATED
Brand Wegovy® paired with structured 1:1 coaching, a published clinical protocol and follow-up. Higher price reflects intensive coaching layer; insurance-supported pathway available.
UPDATED
Compounded semaglutide via async NP-led intake with a published clinical protocol. Async-only model and limited pharmacy traceability are the key gaps.
UPDATED
WeightWatchers' clinical arm. $99/mo membership plus medication cost (typically Wegovy® via insurance). Behavioral-program integration is the differentiator.
UPDATED
Mass-market telehealth scale. Mixed compounded and brand semaglutide options. Pricing toward the low end. Publishes a clinical protocol but limited outcome reporting.
UPDATED
Insurance-billing brand telehealth. $0 patient cost when in-network. Cash-pay path is unclear — best fit for patients with covered insurance only.
UPDATED
Mixed model — branded GLP-1s plus compounded options. Limited public disclosure on pharmacy and outcomes.
UPDATED
NP-led compounded semaglutide model with a published clinical protocol and follow-up cadence. Pricing is competitive in the compounded segment.
UPDATED
Behavioral-program-led brand telehealth. Strongest fit for users already in the Noom ecosystem.
We're committed to providing accurate, unbiased information.
All content reviewed by healthcare professionals
Unbiased comparisons with no hidden agendas
Pricing and availability refreshed regularly
Seven weighted scoring categories, 100 points